Breaking News Instant updates and real-time market news.

SSNLF

Samsung

, AAPL

Apple

$144.29

-0.87 (-0.60%)

12:40
06/16/17
06/16
12:40
06/16/17
12:40

Samsung ready to launch Bixby in the U.S. in preview form, Axios reports

Samsung (SSNLF) is ready to launch its twice-delayed Bixby voice assistant in the U.S., but only in preview form for now, Axios reports. Samsung plans to expand Bixby's abilities "over time," including to third-party applications, the report says. Samsung's voice assistant will challenge offerings from Apple (AAPL), Amazon (AMZN) and Google (GOOG, GOOGL). Reference Link

SSNLF

Samsung

AAPL

Apple

$144.29

-0.87 (-0.60%)

AMZN

Amazon.com

$964.17

-12.3 (-1.26%)

GOOG

Alphabet

$942.31

-8.45 (-0.89%)

GOOGL

Alphabet Class A

$960.18

-7.75 (-0.80%)

  • 28

    Jun

  • 19

    Jul

SSNLF Samsung

04/05/17
CHLM
04/05/17
NO CHANGE
Target $18
CHLM
Buy
STMicroelectronics to benefit from content jump in iPhone 8, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss raised his STMicroelectronics' (STM) March and June quarter estimates to account for content increases in Samsung's (SSNLF) Galaxy S8 and Apple's (AAPL) iPhone 8, coupled with continued strong demand for the Nintendo (NTDOY) Switch and strength in the company's connected car business. The analyst says STMicroelectronics remains one of his top names in 2017 and would be a buyer heading into both the S8 and iPhone 8 launches. He reiterates a Buy rating and $18 price target on STMicroelectronics' shares.
04/28/17
NEED
04/28/17
NO CHANGE
Target $108
NEED
Buy
Skyworks price target raised to $108 from $92 at Needham
Needham analyst N. Quinn Bolton raised his price target for Skyworks (SWKS) to $108 from $92 after the company delivered another beat and raise quarter driven by content gains at Huawei and Samsung (SSNLF) and issued a strong outlook for the rest of 2017. The analyst reiterates a Buy rating on the Skyworks' shares.
04/28/17
CHLM
04/28/17
NO CHANGE
Target $120
CHLM
Buy
Skyworks price target raised to $120 from $110 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss raised his price target for Skyworks (SWKS) to $120 from $110 after the company reported results and guidance above estimates driven by content expansion in Samsung's (SSNLF) Galaxy S8 and at Huawei, and continued strength in its Internet of Things business. The analyst reiterates a Buy rating on the shares.
05/17/17
MSCO
05/17/17
NO CHANGE
Target $177
MSCO
Overweight
Apple target raised to $177 at Morgan Stanley after survey shows rising loyalty
Morgan Stanley analyst Katy Huberty reported that the firm's recent survey of 1,000 U.S. consumers shows a rising iPhone retention rate, with 92% of iPhone owners who see upgrading their phone in the next 12 months saying they plan to stick to an iPhone, up from the 86% retention rate in last year's survey. Apple's (AAPL) 92% loyalty rate "dwarfs" that of all other vendors, with its biggest competitor, Samsung (SSNLF), seeing a 77% retention rate, she noted. Huberty, who sees Apple being positioned to gain increasing U.S. smartphone share, raised her price target on Apple to $177 from $161 and keeps an Overweight rating on the stock.
AAPL Apple
$144.29

-0.87 (-0.60%)

06/16/17
MSCO
06/16/17
NO CHANGE
Target $177
MSCO
Overweight
Recent Apple pullback largely due to overall tech weakness, says Morgan Stanley
Morgan Stanley analyst Katy Huberty believes the recent pullback in Apple shares, which are down 7% in the last week, is largely a result of overall weakness in the tech sector and not a change in investor sentiment towards the stock. She notes that Apple shares have risen an average of 18% in the 3 months prior to iPhone announcements over the last ten years, which she believes suggests the recent weakness creates an attractive opportunity to buy the stock. Huberyty keeps an Overweight rating and $177 price target on Apple.
06/15/17
SBSH
06/15/17
NO CHANGE
Target $163
SBSH
Buy
Citi on Apple buying athenahealth? 'Never say never'
After CNBC reported that Apple (AAPL) is working on making the iPhone into a centralized management of patient health data, Citi analyst Garen Sarafian says athenahealth (ATHN) is a "well-suited candidate" to help. In a research note titled "Apple For athenahealth? Never Say Never," the analyst argues that athenahealth would accelerate Apple's efforts for interoperability. He believes Apple "would be one of few homes" that CEO Jonathan Bush would consider. Sarafian has a Buy rating on athenahealth with a $163 price target. The digital provider of medical records is down 42c to $142.34 in midday trading.
06/15/17
UBSW
06/15/17
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit price target raised to $35 from $30 at UBS
UBS analyst Steven Milunovich raised his price target on Jabil Circuit (JBL) to $35 from $30 following solid Q3 results and its positive 2018 outlook. The analyst said the company still has a 24% revenue dependence on Apple (AAPL). Based on its guidance for 2018, it must have reasonable confidence in the iPhone 8 cycle, said Milunovich, who reiterated his Buy rating on Jabil shares.
06/15/17
COWN
06/15/17
NO CHANGE
Target $160
COWN
Outperform
Jabil Circuit results indicate no glaring issues for Apple, says Cowen
Cowen analyst Timothy Arcuri noted that Jabil Circuits' (JBL) results beat estimates and the company raised guidance. He said the read-through from the report indicate no glaring issues for the iPhone launch. His field work suggests Apple's (AAPL) June quarter is ok, but the September iPhone supply still appears roughly 3-4M below what is implied by the Street. Arcuri maintains his Outperform rating and $160 price target on Apple shares.
AMZN Amazon.com
$964.17

-12.3 (-1.26%)

06/16/17
JEFF
06/16/17
NO CHANGE
Target $39
JEFF
Buy
Jefferies does not expect higher bid for Whole Foods
Jefferies analyst Christopher Mandeville does not see a higher bid coming for Whole Foods (WFM) given the premium paid by Amazon.com (AMZN). The analyst believes the synergies from the deal are "unclear at this time." He also expects grocery stocks to remain under pressure following today's news. Further, United Natural Foods' (UNFI) relationship with Whole Foods is now "more questionable than ever," Mandeville tells investors in a research note.
06/16/17
RBCM
06/16/17
NO CHANGE
RBCM
Amazon deal shouldn't directly hurt foodservice distributors, says RBC Capital
RBC Capital said Amazon's (AMZN) deal for Whole Foods (WFM) should not have a direct negative impact on foodservice distributors such as Sysco (SYY), US Foods (USFD) and Performance Food Group (PFGC), noting that there is not enough dock space at Whole Foods to help the e-commerce giant service restaurant needs, though they do acknowledge that combo may take a "small share" from restaurant occasions.
06/16/17
BUCK
06/16/17
NO CHANGE
BUCK
United Natural Foods' Whole Foods contract will remain in place, says Buckingham
Buckingham said the selloff in United Natural Food's (UNFI) shares is due to concerns relating to the future of its contract with Whole Foods (WFM) following the acquisition by Amazon.com (AMZN). Upon the change of control, the firm's analyst said the contract will be transferred to Amazon, where it will remain in place until September 2015 and sees no near-term earnings impact to United Natural based on the transaction.
06/16/17
LEHM
06/16/17
UPGRADE
Target $48
LEHM
Overweight
Barclays upgrades Whole Foods on potential for bidding war
As previously reported, Barclays analyst Karen Short upgraded Whole Foods (WFM) to Overweight from Equal Weight and raised her price target on the stock to $48 from $38, telling investors that she would not be surprised to see a bidding war break out following Amazon's (AMZN) announcement of a takeover agreement. Short, who thinks a strategic retail buyer would generate up to $600M in synergies from a deal to buy Whole Foods, said bidders could include Kroger (KR), Target (TGT), and Wal-Mart (WMT), all of which may "have too much to lose not to bid."
GOOG Alphabet
$942.31

-8.45 (-0.89%)

06/15/17
06/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Hold from Buy at Canaccord with analyst Michael Graham citing valuation. Graham maintained his $1,000 price target on Alphabet shares. 2. Mattel (MAT) downgraded to Neutral from Buy at DA Davidson with analyst Linda Bolton saying near-term business fundamentals have deteriorated after the company cut its dividend by 61%. 3. Brinker (EAT) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe saying he expects higher spending and weak industry trends to offset any possible sales improvement. 4. Terex (TEX) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revinch citing valuation. 5. Splunk (SPLK) downgraded to Neutral from Outperform at Wedbush analyst Steve Koenig citing the emergence of "meaningful competition," the "complexity" of its transition to the cloud, and "somewhat messy fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/15/17
06/15/17
NO CHANGE

FANG fundamentals still strong but stocks may moderate, says Canaccord
Canaccord analyst Michael Graham noted the FANG stocks - Facebook (FB),Amazon (AMZN), Netflix (NFLX), and Google parent Alphabet (GOOG) - outpaced the S&P by a great deal and he feels even though fundamentals remain strong, the shares' momentum may begin to moderate. Graham believes most of the growth opportunities in tech remain with the FANG group but he believes valuations are quite reasonable. He downgraded Alphabet to Hold from Buy and believes that Amazon is the one to own long-term.
06/15/17
ADAM
06/15/17
DOWNGRADE
Target $1000
ADAM
Hold
Alphabet downgraded to Hold on valuation at Canaccord
As previously reported, Canaccord analyst Michael Graham downgraded Alphabet to Hold from Buy citing valuation. The analyst still believe growth opportunities exist but the valuation is inline and he believes investors should take a step back. Graham maintained his $1,000 price target on Alphabet shares.
06/14/17
UBSW
06/14/17
NO CHANGE
Target $32
UBSW
Buy
Mindbody focus on high value subscribers the right strategy, says UBS
UBS analyst Ian Strgar said MindBody (MB) is now focused on high value subscribers, which he believes is the right strategy and should lead to a higher long-term average monthly revenue per subscriber, leading to a reacceleration of earnings and revenues. The analyst also sees the potential for an acquisition helping the strategy. He adds that its partnership with Google (GOOG) remains in its early innings and helps on the road to $1B in revenues. Strgar reiterated his Buy rating and raised his price target to $32 from $30 on MindBody shares.
GOOGL Alphabet Class A
$960.18

-7.75 (-0.80%)

06/15/17
ADAM
06/15/17
DOWNGRADE
ADAM
Hold
Alphabet downgraded to Hold from Buy at Canaccord

TODAY'S FREE FLY STORIES

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

, UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

18:17
09/25/17
09/25
18:17
09/25/17
18:17
Hot Stocks
Senator Collins opposes Graham-Cassidy ACA repeal bill »

U.S. Senator Susan…

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

CNC

Centene

$90.33

-1.89 (-2.05%)

WCG

WellCare

$164.15

-3.01 (-1.80%)

CI

Cigna

$181.44

-1.3 (-0.71%)

ANTM

Anthem

$181.50

-1.36 (-0.74%)

HNT

Health Net

HUM

Humana

$237.21

-1.88 (-0.79%)

AET

Aetna

$151.98

-1.59 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

18:15
09/25/17
09/25
18:15
09/25/17
18:15
General news
Breaking General news story  »

Minneapolis Federal…

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

18:13
09/25/17
09/25
18:13
09/25/17
18:13
Downgrade
Cardtronics rating change  »

Cardtronics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$7.80

-0.5 (-6.02%)

18:10
09/25/17
09/25
18:10
09/25/17
18:10
Recommendations
Invuity analyst commentary  »

Invuity's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

, UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

18:05
09/25/17
09/25
18:05
09/25/17
18:05
Hot Stocks
CBO: Graham-Cassidy ACA repeal bill to reduce number of insured by 'millions' »

The Congressional Budget…

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

CNC

Centene

$90.33

-1.89 (-2.05%)

WCG

WellCare

$164.15

-3.01 (-1.80%)

CI

Cigna

$181.44

-1.3 (-0.71%)

ANTM

Anthem

$181.50

-1.36 (-0.74%)

HNT

Health Net

HUM

Humana

$237.21

-1.88 (-0.79%)

AET

Aetna

$151.98

-1.59 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

GPC

Genuine Parts

$93.22

5.24 (5.96%)

18:04
09/25/17
09/25
18:04
09/25/17
18:04
Recommendations
Genuine Parts analyst commentary  »

Genuine Parts acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

  • 30

    Oct

AA

Alcoa

$45.29

-0.09 (-0.20%)

, FCX

Freeport McMoRan

$13.89

-0.17 (-1.21%)

17:55
09/25/17
09/25
17:55
09/25/17
17:55
Recommendations
Alcoa, Freeport McMoRan, Teck Resources, Newmont Mining, Warrior Met Coal, Cleveland-Cliffs analyst commentary  »

Morgan Stanley raising…

AA

Alcoa

$45.29

-0.09 (-0.20%)

FCX

Freeport McMoRan

$13.89

-0.17 (-1.21%)

TECK

Teck Resources

$21.24

-0.72 (-3.28%)

NEM

Newmont Mining

$38.63

0.74 (1.95%)

HCC

Warrior Met Coal

$24.11

0.76 (3.25%)

CLF

Cleveland-Cliffs

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 20

    Oct

  • 26

    Oct

17:55
09/25/17
09/25
17:55
09/25/17
17:55
Conference/Events
Federal Reserve Bank of Minneapolis President participates in a discussion »

Minneapolis Federal…

FTK

Flotek

$5.40

0.04 (0.75%)

17:49
09/25/17
09/25
17:49
09/25/17
17:49
Earnings
Flotek cuts Q3 revenue view by $5M, consensus $90.9M »

Flotek announced impacts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 14

    Nov

  • 16

    May

NBLX

Noble Midstream

$54.11

3.75 (7.45%)

17:44
09/25/17
09/25
17:44
09/25/17
17:44
Recommendations
Noble Midstream analyst commentary  »

Noble Midstream guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 31

    Oct

FB

Facebook

$162.87

-7.67 (-4.50%)

17:38
09/25/17
09/25
17:38
09/25/17
17:38
Periodicals
Russia looked to 'exploit' divisions in U.S. populace with Facebook ads, WP says »

The collection of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

ASNA

Ascena Retail

$2.17

0.07 (3.33%)

, SNX

Synnex

$116.50

0.4 (0.34%)

17:35
09/25/17
09/25
17:35
09/25/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Ascena…

ASNA

Ascena Retail

$2.17

0.07 (3.33%)

SNX

Synnex

$116.50

0.4 (0.34%)

RHT

Red Hat

$105.76

-0.54 (-0.51%)

ACTA

Actua

$12.25

-0.1 (-0.81%)

PRQR

ProQR Therapeutics

$6.45

0.25 (4.03%)

GNCA

Genocea

$5.33

0.04 (0.76%)

KDMN

Kadmon

$3.79

0.27 (7.67%)

QEP

QEP Resources

$8.88

0.51 (6.09%)

TXMD

TherapeuticsMD

$6.06

-0.11 (-1.78%)

BIOP

Bioptix

$4.11

-0.16 (-3.75%)

CSGP

CoStar Group

$279.20

-1.62 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 27

    Sep

  • 16

    Oct

  • 17

    Oct

  • 03

    Nov

  • 26

    Sep

GKOS

Glaukos

$31.26

-0.93 (-2.89%)

17:30
09/25/17
09/25
17:30
09/25/17
17:30
Hot Stocks
Breaking Hot Stocks news story on Glaukos »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOP

Bioptix

$4.11

-0.16 (-3.75%)

17:28
09/25/17
09/25
17:28
09/25/17
17:28
Hot Stocks
Bioptix changes state of incorporation to Nevada from Colorado »

Bioptix said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$254.32

-2.13 (-0.83%)

17:26
09/25/17
09/25
17:26
09/25/17
17:26
Hot Stocks
Boeing and Qatar Airways announce order valued at $2.16B »

Boeing and Qatar Airways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CLXT

Calyxt

$26.54

0.82 (3.19%)

17:25
09/25/17
09/25
17:25
09/25/17
17:25
Hot Stocks
Calyxt: Herbicide-tolerant wheat, oil composition canola move to Phase 1 »

Calyxt announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MNK

Mallinckrodt

$35.25

0.42 (1.21%)

17:03
09/25/17
09/25
17:03
09/25/17
17:03
Earnings
Mallinckrodt sees InfaCare acquisition 15c-20c dilutive to FY17 adjusted EPS »

Mallinckrodt announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

FTI

TechnipFMC

$27.02

0.19 (0.71%)

17:02
09/25/17
09/25
17:02
09/25/17
17:02
Hot Stocks
TechnipFMC implements share repurchase of up to $500M »

TechnipFMC announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

GNCA

Genocea

$5.33

0.04 (0.76%)

17:01
09/25/17
09/25
17:01
09/25/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Genocea 

Genocea trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TXMD

TherapeuticsMD

$6.06

-0.11 (-1.78%)

16:53
09/25/17
09/25
16:53
09/25/17
16:53
Syndicate
TherapeuticsMD files to sell 12.4M shares of common stock »

J.P. Morgan is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Nov

LLL

L3 Technologies

$189.32

0.04 (0.02%)

16:52
09/25/17
09/25
16:52
09/25/17
16:52
Hot Stocks
L3 Technologies files protest with GAO related to Fort Rucker contract »

L3 Technologies announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRI

Apricus Biosciences

$1.73

0.05 (2.98%)

16:50
09/25/17
09/25
16:50
09/25/17
16:50
Syndicate
Apricus Biosciences requests withdrawal of registration statement »

The company confirms that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

CDXS

Codexis

16:48
09/25/17
09/25
16:48
09/25/17
16:48
Hot Stocks
Breaking Hot Stocks news story on Codexis »

Vivo Ventures lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 29

    Sep

  • 16

    Nov

AGRO

Adecogro

$10.05

-0.12 (-1.18%)

16:45
09/25/17
09/25
16:45
09/25/17
16:45
Hot Stocks
Adecoagro refinances majority of debt »

Adecoagro announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIBT

RiceBran

$1.21

-0.03 (-2.42%)

16:44
09/25/17
09/25
16:44
09/25/17
16:44
Hot Stocks
Breaking Hot Stocks news story on RiceBran »

Continental Grain reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.